
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+16
BioStrand, a subsidiary of ImmunoPrecise Antibodies (IPA), operates at the intersection of biotech, life science, (bio)informatics, and AI. Our unique capabilities allow us to analyse large data sets with remarkable accuracy, providing groundbreaking insights in therapeutic and diagnostic research. Our patented HYFT technology and LENSai TM Integrated Intelligence Platform make it possible to apply these capabilities across numerous life science disciplines. We are deeply committed to developing a next-generation end-to-end omics drug development platform that harnesses our advanced tools to accelerate discoveries. Lets collaborate today. https://www.biostrand.ai
Structural genetics,data analytics,sequence analysis,cloud-based,big data,knowledge graphs,nlp,in silico drug discovery,ai drug discovery,life sciences,ai drug development,biotechnology,data management,bioinformatics,llms in drug discovery,multi omics analysis,protein structure prediction,cloud computing,alphafold,antibody discovery,and data science
Biostrand (a subsidiary of ipa) operates in the Biotechnology research industry.
Biostrand (a subsidiary of ipa)'s revenue is 11m - 100m
Biostrand (a subsidiary of ipa) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.